All terms in MESH
| Label | Id | Description |
|---|---|---|
| 4-nitrophenyl methyl(4-trifluoromethylphenyl)phosphinate | C064172 | |
| 6-methoxycarbonyl-3-cyclohexene-1-carboxylic acid | C064173 | |
| 3-(2-oxopropylidene)azetidin-2-one | C064174 | |
| 3-(4-azidobenzoyloxy)diltiazem | C064175 | |
| alpha-viniferin | C064176 | |
| 2'-demethoxy-2'-methyldehydrogriseofulvin | C064177 | |
| 2'-demethoxy-2'-methylgriseofulvin | C064178 | |
| interferon regulatory factor-8 | C064179 | |
| Nervous System | D009420 | [The entire nerve apparatus, composed of a central part, the brain and spinal cord, and a peripheral part, the cranial and spinal nerves, autonomic ganglia, and plexuses. (Stedman, 26th ed)] |
| Central Nervous System Agents | D002491 | [A class of drugs producing both physiological and psychological effects through a variety of mechanisms. They can be divided into "specific" agents, e.g., affecting an identifiable molecular mechanism unique to target cells bearing receptors for that agent, and "nonspecific" agents, those producing effects on different target cells and acting by diverse molecular mechanisms. Those with nonspecific mechanisms are generally further classed according to whether they produce behavioral depression or stimulation. Those with specific mechanisms are classed by locus of action or specific therapeutic use. (From Gilman AG, et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p252)] |
| Systematic Review | D000078182 | [A review of primary literature in health and health policy that attempts to identify, appraise, and synthesize all the empirical evidence that meets specified eligibility criteria to answer a given research question. Its conduct uses explicit methods aimed at minimizing bias in order to produce more reliable findings regarding the effects of interventions for prevention, treatment, and rehabilitation that can be used to inform decision making.] |
| Central Nervous System Depressants | D002492 | [A very loosely defined group of drugs that tend to reduce the activity of the central nervous system. The major groups included here are ethyl alcohol, anesthetics, hypnotics and sedatives, narcotics, and tranquilizing agents (antipsychotics and antianxiety agents).] |
| Nervous System Diseases | D009422 | [Diseases of the central and peripheral nervous system. This includes disorders of the brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, autonomic nervous system, neuromuscular junction, and muscle.] |
| Bacterial Infections and Mycoses | D001423 | [Infections caused by bacteria and fungi, general, specified, or unspecified.] |
| Central Supply, Hospital | D002495 | [Hospital department responsible for receiving, storing, and distributing medical and surgical supplies and equipment.] |
| Central Venous Pressure | D002496 | [The blood pressure in the central large VEINS of the body. It is distinguished from peripheral venous pressure which occurs in an extremity.] |
| Venous Pressure | D014690 | [The blood pressure in the VEINS. It is usually measured to assess the filling PRESSURE to the HEART VENTRICLE.] |
| Centralized Hospital Services | D002497 | [The coordination of services in one area of a facility to improve efficiency.] |
| Hospital Administration | D006739 | [Management of the internal organization of the hospital.] |
| MIRN219 microRNA, rat | C000591851 |